Starting shortly Do tune in This is a huge meeting with more than 5000 attendees Some snapshots from last nights stunning performances at the cultural program

Loved this deep and diverse session! Biopharma audience of bright scientists start-ups Big Pharma CEOs investors & Govt officials was new & unique! Happy to represent CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC ACTREC-TMC Tata Memorial Hospital & report the future’s bright 😎 Correcting tag 👇🏻ImPaCCT Foundation Shalini Jatia

Very happy to announce the 4th in series #SACT2025 event CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC -already the largest #CellGeneRx meeting in India & the part of the world! Looking forward to meeting you all! We’ve moved to a 1000 capacity hall to accommodate the demand! Watch this space for announcements!

Early Bird Registrations Now Open for 4th SACT EVENT 2025 at ACTREC, Tata Memorial Centre Avail 20% Early Bird Discount! 18+ Intl. Speakers, 8 Tracks, Hands-On Training & more! Register now: sactevent.in/registration-f…  #SACTEvent2025 Gaurav Narula MD Albeena Nisar CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC

For all Cell Therapy experts in India & across the APAC region—Academia & Industry! Don’t miss this unique opportunity to present your research at Our 4th Annual APAC Cell Therapy Conference, SACT 2025 !! CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC ACTREC-TMC Gaurav Narula MD Join 25+ global pioneers from

Gaurav Narula MD Albeena Nisar CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC ACTREC-TMC MD Anderson Cancer Center Meet the trailblazing minds at #SACT2025! Dr. Emily Hopewell, Dr. Stephan Kadauke, & Dr. Lucas Chan leading the Manufacturing & CMC track. Early Bird Registration (30% OFF) is OPEN! Register & submit abstracts: lnkd.in/dRT3gDwe Gaurav Narula MD Albeena Nisar CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC

Gaurav Narula MD Albeena Nisar CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC ACTREC-TMC MD Anderson Cancer Center Don’t Miss Out on SACT 2025! Abstract Submission Deadline: Dec 31, 2024! Join us by submit your abstract now & take advantage of our holiday discounts! sactevent.in/abstract-submi… #holidaydiscount #SACT2025 Gaurav Narula MD Albeena Nisar CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC ACTREC-TMC

Advancing Neuroblastoma Treatment with Allogeneic GD2-CAR T Cells cgtxpress.com/f/advancing-ne…

Prof James Allison The Nobel Prize laureate MD Anderson Cancer Center delivering the 6th #IOSICON Immuno-Oncology Society of India Oration at Bhubaneswar- history unfolding of the path from bench to bedside of the greatest discovery in cancer in the last few decades 👏🏻👏🏻👏🏻#IndoUSCancerMoonshot

Thank you IMAPAC, Biopharma Excellene Awards for Research Excellence in Biopharma #CART #CGT field, we are honoured to receive the award Gaurav Narula MD for CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC ACTREC-TMC for Research work in 2024-2025. Gratitude 🙏 Cancer Research Institute - ACTREC ACTREC-TMC Tata Memorial Hospital

A dazzling array of First-in-Human NK cell based trials by the thought and action leader in the field Katy Rezvani, M.D., Ph.D So much done in the last decade and she’s just getting started Wonderful session at SACT 2025 (Series on Advancements in Cell Therapy)

A labor of love dreams and persistence From preclinical through translational, multiple regulatory hoops & clinical trials- congrats Hasmukh Jain and Adult Hematolymphoid group Tata Memorial Hospital for this historic trial ImmunoACT Rahul Purwar Our #CARTCellRx put 🇮🇳on #CellGeneRx map!

Congratulations Gaurav Narula MD Sir and team ACTREC-TMC and IIT Bombay for this monumental achievement. The journey is indeed an inspirational one. Rahul Purwar Albeena Nisar Khushali Pandit CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC

Ultra-Fast CAR-T. Exciting phase 1 results with improvements in both safety and efficacy 🌠Watch out for our poster at ISCT 2025. Promising study led by David Wald & Jan Joseph Melenhorst sciencedirect.com/science/articl…

(1/4) India moves closer to innovative cancer care! An ICMR-funded Phase 1 trial led by @CMC_Vellore, published in Molecular Therapy, demonstrates CAR-T therapy, which uses patient’s own T cells to fight cancer, can be safely manufactured & infused at point of care in India at low cost

Treating the untreatable - "Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure" Penn Medicine @nejm #immunotherapy nejm.org/doi/full/10.10…

Thanks to Department of Biotechnology DBT-BIRAC and Dr Gokhale for highlighting the CAR-T as science with compassion, access and affordability. We will continue to work hard to improve access of such high quality-life saving medicines at affordable cost. Dr Jitendra Singh IIT Bombay ImmunoACT

Truly an honor discussing some of our work at THSTI, a DBT institute. Interacted with friends, colleagues and students. Thanks a lot DBT-THSTI , Dr Karthikeye, Dr Amit, Dr Batra and entire team for the invite and warm hospitality.

We, the Weizmann Institute of Science community, deeply mourn the passing of Prof. Zelig Eshhar of the Department of Immunology and Regenerative Biology. Prof. Eshhar was a trailblazing scientist in the field of cancer immunotherapy, a recipient of the Israel Prize in Life